Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.93
-0.01 (-0.08%)
Aug 29, 2025, 4:00 PM - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $8.15 billion as of August 29, 2025. Its market cap has decreased by -3.62% in one year.
Market Cap
8.15B
Enterprise Value
3.74B
1-Year Change
-3.62%
Ranking
Category
Stock Price
$11.93
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $8.15B, an increase of 1,427.40%. That is a compound annual growth rate of 78.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 8.15B | -5.40% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
| Dec 8, 2020 | 533.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |